Novo Nordisk stock has been pretty volatile lately, making it hard to judge whether now is a good opportunity to buy shares.
A Scandinavian economic behemoth, Novo Nordisk is the highest valued company in Europe at over $500 billion, which ...
Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great ...
Novo Nordisk's Wegovy launch in China begins in Shanghai at $194 per four-injection pack, significantly cheaper than ...
The move intensifies the competition with Eli Lilly, which secured approval for its weight loss drug in China in July but has ...
The company narrowed its full-year guidance as its blockbuster weight-loss drug soars in popularity.
Readouts from Novo Nordisk and Viking Therapeutics at AASLD 2024 strengthen the argument for GLP-1 therapies as an emerging ...
GlobalData on MSN13d
Strong Wegovy revenue growth for Novo Nordisk but shares dipNovo Nordisk’s net profit of $3.94bn represents a 21% increase from Q3 2023. Net sales in the quarter jumped by the same ...
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback